Estrogen-IGF-1 Interactions in Neuroprotection: Ischemic Stroke As a Case Study
Overview
Authors
Affiliations
The steroid hormone 17b-estradiol and the peptide hormone insulin-like growth factor (IGF)-1 independently exert neuroprotective actions in neurologic diseases such as stroke. Only a few studies have directly addressed the interaction between the two hormone systems, however, there is a large literature that indicates potentially greater interactions between the 17b-estradiol and IGF-1 systems. The present review focuses on key issues related to this interaction including IGF-1 and sex differences and common activation of second messenger systems. Using ischemic stroke as a case study, this review also focuses on independent and cooperative actions of estrogen and IGF-1 on neuroprotection, blood brain barrier integrity, angiogenesis, inflammation and post-stroke epilepsy. Finally, the review also focuses on the astrocyte, a key mediator of post stroke repair, as a local source of 17b-estradiol and IGF-1. This review thus highlights areas where significant new research is needed to clarify the interactions between these two neuroprotectants.
Estradiol metabolism by gut microbiota in women's depression pathogenesis: inspiration from nature.
Zhang W, Jia J, Yang Y, Ye D, Li Y, Li D Front Psychiatry. 2025; 16:1505991.
PMID: 39935532 PMC: 11811108. DOI: 10.3389/fpsyt.2025.1505991.
Oestrogen treatment restores dentate gyrus development in premature newborns by IGF1 regulation.
Sharma D, Cheng B, Sahu R, Zhang X, Mehdizadeh R, Singh D J Cell Mol Med. 2023; 27(17):2467-2481.
PMID: 37594177 PMC: 10468667. DOI: 10.1111/jcmm.17816.
Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis.
Bickel M, Csik B, Gulej R, Ungvari A, Nyul-Toth A, Conley S Front Endocrinol (Lausanne). 2023; 14():1087053.
PMID: 36755922 PMC: 9900125. DOI: 10.3389/fendo.2023.1087053.
Localisation of oestrogen receptors in stem cells and in stem cell-derived neurons of the mouse.
Davis D, Vajaria R, Delivopoulos E, Vasudevan N J Neuroendocrinol. 2022; 35(2):e13220.
PMID: 36510342 PMC: 10909416. DOI: 10.1111/jne.13220.
Baumgartner N, McQuillen S, Perry S, Miller S, Maroteaux M, Gibbs R J Neurosci. 2022; 42(42):7969-7983.
PMID: 36261268 PMC: 9617614. DOI: 10.1523/JNEUROSCI.0588-22.2022.